SCHEMBL7959533

SCHEMBL7959533

OC1(c2cccc(Cl)c2Cl)CCN(CCCc2nnc3n2CCCCC3)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.48
DRD3 P35462 2/20 0.42
CHRM2 P08172 1/20 0.42
HTR1A P08908 1/20 0.42
ADRA2A P08913 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA1D P25100 1/20 0.42
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
SLC6A4 P31645 1/20 0.42
ADRA1A P35348 1/20 0.42
HTR2B P41595 1/20 0.42
GAA P10253 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
DRD4 P21917 1/20 0.41
POLB P06746 2/20 0.40
LMNA P02545 3/20 0.38
HPGD P15428 1/20 0.38
SHMT2 P34897 1/20 0.38
HSD11B1 P28845 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7957105 0.92 DRD2 (0.46) DRD2DRD3CHRM2HTR1AADRA2A
SCHEMBL7949233 0.85 CHRM2 (0.44) DRD3CHRM2HTR1AADRA2AADRA2B
SCHEMBL7959714 0.83 GAA (0.50) DRD2DRD3CHRM2HTR1AADRA2A
SCHEMBL7959708 0.82 DRD2 (0.55) DRD2DRD3HTR1AHTR2ASLC6A4
SCHEMBL7960165 0.81 PKM (0.52) DRD2DRD3CHRM2HTR1AADRA2A
SCHEMBL7963844 0.81 LMNA (0.45) DRD2DRD3CHRM2HTR1AADRA2A
SCHEMBL7963703 0.81 HSD11B1 (0.41) DRD2DRD3CHRM2HTR1AADRA2A
SCHEMBL7959422 0.80 DRD2 (0.44) DRD2DRD3CHRM2HTR1AADRA2A
SCHEMBL7957371 0.79 LMNA (0.52) DRD2DRD3HTR1AHTR2AHTR2C
SCHEMBL7959210 0.79 DRD2 (0.45) DRD2DRD3CHRM2HTR1AADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed